menu
    • menu

    Company profile for Enveda Bioscience

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At Enveda, we’re harnessing the complexity of the natural world to tackle today’s biggest healthcare challenges. With breakthrough advancements in machine learning, computational metabolomics, and knowledge graphs, we’re discovering the next generation of small molecules.Our technologies systematize discovery of first-in-class small molecules and novel targets for complex diseases. By probing novel chemical space and mec...
    At Enveda, we’re harnessing the complexity of the natural world to tackle today’s biggest healthcare challenges. With breakthrough advancements in machine learning, computational metabolomics, and knowledge graphs, we’re discovering the next generation of small molecules.Our technologies systematize discovery of first-in-class small molecules and novel targets for complex diseases. By probing novel chemical space and mechanisms of action, we are breaking the status quo for challenging diseases with a need for effective treatments, such as fibrosis or neurodegeneration. At we are systematically translating molecules found in medicinal

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Enveda BioscienceUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    611 Gateway Blvd, Suite 120, South San Francisco, CA 94080
    Telephone
    Telephone
    +1-415-323-5252
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.envedabio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/envedabio/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Enveda Secures Additional $150M to Advance Nature-Inspired Drugs
    Enveda Secures Additional $150M to Advance Nature-Inspired Drugs

    04 Sep 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/enveda-harvests-another-150m-advance-nature-inspired-drugs

    FIERCE BIOTECH
    04 Sep 2025
    Share Share
    Enveda Reports Favorable Phase 1 Safety, Launches Phase 1b Trial
    Enveda Reports Favorable Phase 1 Safety, Launches Phase 1b Trial

    28 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250528125414/en/Enveda-Reports-Favorable-Phase-1-Safety-for-Novel-Oral-Anti-Inflammatory-Launches-Phase-1b-Trial-in-Atopic-Dermatitis

    BUSINESSWIRE
    28 May 2025
    Share Share
    Enveda Secures Sanofi Backing, Series C To $150M For AI Discovery
    Enveda Secures Sanofi Backing, Series C To $150M For AI Discovery

    26 Feb 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250226020142/en

    BUSINESSWIRE
    26 Feb 2025
    Share Share
    Enveda Expands into Asthma with ENV-294 & Assembles Advisory Board
    Enveda Expands into Asthma with ENV-294 & Assembles Advisory Board

    05 Feb 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250205061722/en

    BUSINESSWIRE
    05 Feb 2025
    Share Share
    Enveda Announces 1st AI-Discovered Drug Candidate in Clinical Trial
    Enveda Announces 1st AI-Discovered Drug Candidate in Clinical Trial

    13 Nov 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241113334257/en

    BUSINESSWIRE
    13 Nov 2024
    Share Share
    Enveda Biosciences Hires CMO To Advance Clinical Pipeline
    Enveda Biosciences Hires CMO To Advance Clinical Pipeline

    01 Aug 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240801312880/en

    BUSINESSWIRE
    01 Aug 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search